Predictions
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€4.53
02.07.21
02.07.21
-
02.07.22
02.07.22
18.90%
13.07.21
13.07.21
Risky Investment
Medigene AG
Start price
Target price
Perf. (%)
€3.90
02.07.21
02.07.21
-
02.07.22
02.07.22
-20.90%
09.03.22
09.03.22
Innovative
Dependend from some customers or products
Higher risks for its business
Paul Hartmann AG
Start price
Target price
Perf. (%)
€353.00
30.06.21
30.06.21
€400.00
30.06.22
30.06.22
3.40%
10.07.21
10.07.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
SELLAS Life Sciences Group Inc
Start price
Target price
Perf. (%)
€13.06
30.06.21
30.06.21
€16.00
30.06.22
30.06.22
-39.28%
09.07.21
09.07.21
Could be worthwhile Investment >10% per year
Capable Management
Little innovation
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€5.00
30.06.21
30.06.21
€8.00
30.06.22
30.06.22
-22.40%
09.07.21
09.07.21
Could be worthwhile Investment >10% per year
Good culture
Little innovation
Veeva Systems A
Start price
Target price
Perf. (%)
€269.00
29.06.21
29.06.21
€275.00
29.06.22
29.06.22
-29.38%
29.06.22
29.06.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Innovative
Some uniques
Abivax S.A.
Start price
Target price
Perf. (%)
€30.50
28.06.21
28.06.21
€25.00
28.06.22
28.06.22
-16.39%
01.12.21
01.12.21
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Pra Health
Start price
Target price
Perf. (%)
€141.00
28.06.21
28.06.21
€200.00
28.06.22
28.06.22
-0.71%
12.07.21
12.07.21
Could be worthwhile Investment >10% per year
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€72.60
28.06.21
28.06.21
€120.00
28.06.22
28.06.22
-21.07%
12.07.21
12.07.21
Could be worthwhile Investment >10% per year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€146.55
28.06.21
28.06.21
€200.00
28.06.22
28.06.22
-3.62%
12.07.21
12.07.21
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.00
28.06.21
28.06.21
€75.00
28.06.22
28.06.22
-2.98%
12.07.21
12.07.21
Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€46.00
26.06.21
26.06.21
-
26.06.22
26.06.22
-81.82%
27.06.22
27.06.22
Could be very worthwhile Investment >20% year
Osmotica Pharmaceuticals PLC
Start price
Target price
Perf. (%)
€3.04
26.06.21
26.06.21
€1.00
26.06.22
26.06.22
-18.42%
10.07.21
10.07.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€7.20
25.06.21
25.06.21
-
25.06.22
25.06.22
-26.39%
30.06.21
30.06.21
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€16.08
24.06.21
24.06.21
€4.80
24.06.22
24.06.22
-60.12%
20.12.21
20.12.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.92
19.06.21
19.06.21
€58.00
19.06.22
19.06.22
-20.72%
27.12.21
27.12.21
Could be worthwhile Investment >10% per year
Sartorius AG VZO
Start price
Target price
Perf. (%)
€413.70
18.06.21
18.06.21
€600.00
18.06.22
18.06.22
35.75%
27.09.21
27.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€158.36
17.06.21
17.06.21
€165.00
17.06.22
17.06.22
59.60%
18.06.22
18.06.22
Could be worthwhile Investment >10% per year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€11.37
17.06.21
17.06.21
€18.00
09.03.22
09.03.22
95.60%
10.03.22
10.03.22
Could be very worthwhile Investment >20% year